| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 4 | — | — | — | 1 | — | 4 | 2 | — | 2 | — |
| Sell | — | — | — | — | — | — | — | 1 | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2027 | ‡‡‡‡ |
|
| 2026 | 0.81 |
—
—
—
|
| 2025 | 1.33 |
—
—
—
—
|
| 2024 | 1.72 |
—
—
—
—
|
| 2023 | 1.68 |
—
—
—
—
|
| 2022 | 1.54 |
—
—
—
—
|
| 2021 | 1.38 |
—
—
—
—
|
| 2020 | 1.23 |
—
—
—
—
|
| 2019 | 1.14 |
—
—
—
—
|
| 2018 | 0.98 |
—
—
—
—
—
|
| 2017 | 0.72 |
—
—
—
—
|
| 2016 | 0.62 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 1,692.49 | 817.33 | 706.31 | 583.04 |
| Receivables | 64.42 | 12.79 | 6.53 | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 15,077.67 | 12,668.56 | 13,397.01 | 13,197.94 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 135.51 | 52.10 | 33.95 | 27.56 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 418.62 | 337.95 | 33.95 | 27.56 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 292.59 | 293.64 | — | — |
—
|
| ’25 | 299.41 | 301.99 | 297.16 | 313.67 |
1,212.23
|
| ’24 | 378.33 | 362.33 | 354.36 | 331.72 |
1,426.74
|
| ’23 | 401.05 | 400.96 | 405.87 | 416.37 |
1,624.24
|
| ’22 | 225.60 | 251.77 | 294.81 | 404.50 |
1,176.68
|
| ’21 | 169.94 | 186.32 | 195.06 | 247.91 |
799.24
|
| ’20 | 90.83 | 149.80 | 158.63 | 204.46 |
603.72
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (8.27) | 158.25 | — | — |
—
|
| ’25 | 150.55 | 60.05 | 178.73 | (16.94) |
372.38
|
| ’24 | 259.96 | 69.93 | 84.96 | 46.67 |
461.52
|
| ’23 | (56.78) | 158.41 | 57.08 | 77.15 |
235.86
|
| ’22 | 836.83 | (72.28) | 46.56 | 288.54 |
1,099.65
|
| ’21 | 491.09 | 236.49 | (727.98) | 217.25 |
216.85
|
| ’20 | (233.23) | 766.97 | (230.03) | (248.54) |
55.17
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (24.48) | 146.53 | — | — |
—
|
| ’25 | 142.88 | 53.71 | 165.97 | (30.89) |
331.67
|
| ’24 | 259.96 | 83.86 | 82.61 | 45.73 |
472.15
|
| ’23 | (56.78) | 158.41 | 57.08 | 77.15 |
235.86
|
| ’22 | 836.83 | (72.28) | 46.56 | 288.54 |
1,099.65
|
| ’21 | 491.09 | 236.49 | (727.98) | 217.25 |
216.85
|
| ’20 | (233.46) | 767.07 | (222.53) | (247.16) |
63.90
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.00 | (0.20) | — | — |
—
|
| ’25 | 0.16 | 0.12 | 0.20 | 0.07 |
0.56
|
| ’24 | 0.31 | 0.25 | 0.31 | 0.32 |
1.18
|
| ’23 | 0.46 | 0.41 | 0.41 | 0.48 |
1.75
|
| ’22 | 0.40 | 0.41 | 0.36 | 0.49 |
1.67
|
| ’21 | 0.55 | 0.51 | 0.51 | 0.71 |
2.28
|
| ’20 | (0.54) | 0.40 | 0.72 | 0.80 |
1.41
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 11.16 | 10.10 | 11.92 | 7.69 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.88 | 17.74 | 15.94 | 14.33 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 630 | 647 | 659 | 653 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.87 | 2.51 | 2.17 | 1.86 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,176.68 | 1,624.24 | 1,426.74 | 1,212.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.68% | 34.19% | 30.35% | 25.43% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 353.83 | 400.56 | 283.92 | 157.83 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.07% | 24.66% | 19.90% | 13.02% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 353.83 | 400.56 | 283.92 | 157.83 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.06 | 69.22 | 77.27 | 108.76 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.12 | 8.80 | 7.56 | 6.28 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡ | 1.72 | 1.79 | 1.18 | 0.56 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.65 | 1.28 | 2.45 | 1.93 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.06 | (0.21) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.65 | 1.28 | 2.50 | 1.72 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.58 | 17.63 | 16.70 | 15.90 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 165.36 | 184.64 | 188.70 | 192.96 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 7.83 | 8.35 | 11.64 | 14.11 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.90 | 1.71 | 1.83 | 1.24 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.92 | 1.06 | 1.04 | 0.62 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.14 | 6.40 | 6.12 | 6.20 | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.76 | 42.52 | 18.45 | 22.67 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,099.65 | 235.86 | 461.52 | 372.38 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — | 10.63 | (40.72) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,099.65 | 235.86 | 472.15 | 331.67 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16,138.41 | 14,659.05 | 12,330.61 | 13,363.06 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,094.39 | 8,457.21 | 6,078.22 | 5,865.80 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,689.68 | 6,764.73 | 5,260.89 | 5,159.49 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,071.88 | 3,254.61 | 3,151.97 | 3,067.15 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.77% | 2.01% | 1.53% | 0.77% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.88% | 2.68% | 2.18% | 1.59% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.85% | 13.05% | 8.69% | 4.34% | — | — | — |
ROE
|
Arbor Realty Trust (ABR), a leading mREIT focused on bridge and mezzanine loans for multifamily and commercial properties, delivered explosive growth over the past decade, with revenue surging from $213 million in 2016 to a peak of $1.62 billion in 2023. However, rising interest rates, slowing originations, and short-seller attacks like Viceroy Research’s 2024 claims of overstated collateral have pressured performance, leading to a 12% revenue drop in 2024 and analyst forecasts of an 83% plunge to $247 million in 2025 amid CRE distress.
Despite profitability dips—net income down 29% to $284 million in 2024 and EPS projected to halve initially—ABR has deleveraged aggressively, slashing net debt by 46% from peaks, while maintaining a juicy 13% dividend yield. Valuation looks attractive at ~1x book value and 13x forward PE, with ROA holding steady above long-term averages.
Insider buying, led by CEO Ivan Kaufman’s $2.4 million purchases in 2025, signals strong confidence amid share stabilization near lows, countering bearish narratives. With potential rate cuts poised to revive originations and targets implying up to 55% upside, ABR offers asymmetric recovery potential for patient investors—dive into the full analysis for the numbers behind the rebound story.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.